Anti-integrin therapy for retinovascular diseases
- 1 September 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 29 (9) , 935-945
Abstract
Integrins are a family of multi-functional cell-adhesion molecules, heterodimeric receptors that connect extracellular matrix (ECM) to actin cytoskeleton in the cell cortex, thus regulating cellula...Keywords
Funding Information
- NIH-National Eye Institute (R01EY027779)
- Center for Diabetes and Metabolic Diseases, Indiana University
This publication has 69 references indexed in Scilit:
- Ocriplasmin for Vitreoretinal DiseasesJournal of Biomedicine and Biotechnology, 2012
- Divalent cations regulate the folding and activation status of integrins during their intracellular traffickingJournal of Cell Science, 2011
- The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic RetinopathyDiabetes, 2009
- Studies with an Orally Bioavailable αV Integrin Antagonist in Animal Models of Ocular Vasculopathy: Retinal Neovascularization in Mice and Retinal Vascular Permeability in Diabetic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761Investigative Ophthalmology & Visual Science, 2007
- Lebectin and lebecetin, two C-type lectins from snake venom, inhibit α5β1 and αv-containing integrinsMatrix Biology, 2007
- Modulation of Hypoxia-Induced Neovascularization by JSM6427, an Integrin α5β 1 Inhibiting MoleculeCurrent Eye Research, 2007
- SB-267268, a Nonpeptidic Antagonist of αvβ3and αvβ5Integrins, Reduces Angiogenesis and VEGF Expression in a Mouse Model of Retinopathy of PrematurityInvestigative Ophthalmology & Visual Science, 2006
- Integrin Chatter and Vascular Function in Diabetic RetinopathyHormone and Metabolic Research, 1997
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992